ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,443Medicare Part D Prescriptions Filled, Including Refills

Rank: 21 out of 262

$580K Total Retail Price of All Prescriptions

Rank: 11 out of 262

499 Patients Receiving at Least One Drug in Part D
77%Patients 65 Years and Older
64% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in North Dakota
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 499 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

11% of this provider’s 499 patients filled at least one prescription for a schedule three drug, compared to an average of 7%.

Risky Drugs to Seniors

1% of this provider’s 6,496 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$55 was the average price of a prescription from this provider, compared to $50 among peers.

Prescriptions per Patient

21 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in North Dakota
LEVOTHYROXINE SODIUM 442 194 1 2
FUROSEMIDE 409 335 2 4
HYDROCHLOROTHIAZIDE 344 218 3 7
OMEPRAZOLE 331 213 4 5
AMLODIPINE BESYLATE 301 258 5 6
ENALAPRIL MALEATE 287 203 6 27
SIMVASTATIN 269 191 7 1
SERTRALINE HCL 214 144 8 14
METOPROLOL SUCCINATE 206 160 9 11
POLYETHYLENE GLYCOL 3350 196 56 10 42
POTASSIUM CHLORIDE 178 107 11 10
LISINOPRIL 177 151 12 3
HYDROCODONE-ACETAMINOPHEN 174 128 S3 13 15
METFORMIN HCL 169 81 14 9
METOPROLOL TARTRATE 169 128 14 8
TRAZODONE HCL 149 100 16 36
OXYBUTYNIN CHLORIDE ER 148 86 17 102
DONEPEZIL HCL 143 129 18 23
ATORVASTATIN CALCIUM 136 79 19 13
TRAMADOL HCL 130 29 20 18
LOSARTAN POTASSIUM 127 116 21 17
RISPERIDONE 126 106 22 50
CARBAMAZEPINE 116 52 23 166
CITALOPRAM HBR 115 53 24 20
RANITIDINE HCL 113 61 25 62
LANTUS 102 57 26 51
DIVALPROEX SODIUM 101 34 27 117
ATENOLOL 100 51 28 16
GABAPENTIN 99 62 29 19
NAMENDA 95 87 30 37
OLANZAPINE 86 50 31 130
ALLOPURINOL 81 45 32 22
TAMSULOSIN HCL 78 71 33 25
DESMOPRESSIN ACETATE 77 14 34 182
WARFARIN SODIUM 76 76 35 12
ACETAMINOPHEN-CODEINE 72 72 S3 36 108
CARBIDOPA-LEVODOPA 70 70 37 66
LYRICA 68 16 38 86
BACLOFEN 61 0 39 166
DETROL LA 57 26 40 76
QUETIAPINE FUMARATE 54 12 41 71
SPIRONOLACTONE 54 26 41 58
OXYBUTYNIN CHLORIDE 52 14 43 90
COMBIVENT 51 41 44 219
LIPITOR 51 38 44 96
PROPRANOLOL HCL 50 0 46 82
ADVAIR DISKUS 50 38 46 34
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 6, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.